Last $27.01 USD
Change Today -0.25 / -0.92%
Volume 66.7K
BRLI On Other Exchanges
As of 2:52 PM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

bio-reference labs inc (BRLI) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/26/13 - $37.97
52 Week Low
04/23/13 - $24.01
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIO-REFERENCE LABS INC (BRLI)

bio-reference labs inc (BRLI) Related Bloomberg News

View More Bloomberg News

bio-reference labs inc (BRLI) Related Businessweek News

No Related Businessweek News Found

bio-reference labs inc (BRLI) Details

Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases in New Jersey, New York, Maryland, Massachusetts, Texas, and Ohio. The company offers chemical diagnostic tests, such as blood and urine analysis; blood chemistry; hematology services; serology; radio-immuno analysis; toxicology, including drug screening; pap smears; tissue pathology comprising biopsies; and other tissue analysis, as well as cancer cytogenetic testing, genetic testing, and cytology testing services. It focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional health care services. The company also operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data, and other data sources to provide administrative and clinical decision support systems; and a Web-based connectivity portal solution for laboratories and physicians. It serves physicians, geneticists, hospitals, clinics, and correctional and other health facilities. The company was founded in 1981 and is headquartered in Elmwood Park, New Jersey.

3,338 Employees
Last Reported Date: 01/13/14
Founded in 1981

bio-reference labs inc (BRLI) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, P...
Total Annual Compensation: $1.2M
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $449.2K
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $449.2K
Compensation as of Fiscal Year 2013.

bio-reference labs inc (BRLI) Key Developments

Bio-Reference Laboratories Inc. Announces Unaudited Earnings Results for the First Quarter Ended January 31, 2014; Reaffirms Earnings Guidance for the Year 2014

Bio-Reference Laboratories Inc. announced unaudited earnings results for the first quarter ended January 31, 2014. For the quarter, the company reported earnings of $0.11 per diluted share, compared with the prior-year period's $0.31 per diluted share. Revenue was $181.27 million, up from $161.26 million in the same quarter in 2013. The company said extreme weather conditions diminished its net revenues by over $4 million and EPS by $0.05. Operating income was $5,880,000 compared to $15,759,000 a year ago. Income before taxes was $5,255,000 compared to $15,373,000 a year ago. Net income was $2,954,000 compared to $8,665,000 a year ago. The company reaffirmed its growth guidance issued in December 2013, growth in fiscal 2014 may even be stronger than the 10% growth guidance for net revenues, patient count and net income. Excluding the weather impact that it estimates will be a combined $0.10 to $0.12 for first quarter and second quarter BRLI believes that its earlier guidance would be accurate.

Bio-Reference Laboratories Inc., Q1 2014 Earnings Call, Mar 04, 2014

Bio-Reference Laboratories Inc., Q1 2014 Earnings Call, Mar 04, 2014

Bio-Reference Laboratories Inc. to Report Q1, 2014 Results on Mar 04, 2014

Bio-Reference Laboratories Inc. announced that they will report Q1, 2014 results on Mar 04, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRLI:US $27.01 USD -0.25

BRLI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alliance HealthCare Services Inc $30.76 USD -0.33
Foundation Medicine Inc $26.63 USD -1.25
Genomic Health Inc $26.69 USD -1.35
RadNet Inc $4.94 USD +0.05
Sequenom Inc $2.84 USD +0.06
View Industry Companies

Industry Analysis


Industry Average

Valuation BRLI Industry Range
Price/Earnings 18.9x
Price/Sales 1.0x
Price/Book 2.7x
Price/Cash Flow 12.4x
TEV/Sales 0.9x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-REFERENCE LABS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at